Posted by Lamdage22 on August 19, 2014, at 14:30:37
In reply to Re: Ketamine pipeline » phidippus, posted by jrbecker76 on August 19, 2014, at 10:56:07
> The data from ketamine-like compounds is actually quite compelling. I have been involved in a number of clinical trials, including intraveneous ketamine, Decoglurant (aka RO4995819, RG1578 - a mGlu2 antag) as well as GLYX-13 (a partial Glycine agonist). Although I was personally not a responder to these treatments, the trials as a whole have produced significant efficacy that are pushing them towards late-stage clinical trial development. On a related note, J&J's intranasal Esketamine as well as Cerecor's CERC-301 have both received the FDA's Fast-Track status.
Glyx-13 is also on fast-track.
Schizophrenia or Schizo-affective
Seroquel 700mg
Zyprexa 10mg
Lithium Carbonate 100mg
Metformin 1500mg
Effexor 37.5 mg
poster:Lamdage22
thread:1069138
URL: http://www.dr-bob.org/babble/20140815/msgs/1070021.html